Literature DB >> 16391783

Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer.

Tetsuro Matsunobu1, Toshiyuki Ishiwata, Masanori Yoshino, Masanori Watanabe, Mitsuhiro Kudo, Koshi Matsumoto, Akira Tokunaga, Takashi Tajiri, Zenya Naito.   

Abstract

The keratinocyte growth factor receptor, also known as KGFR/FGFR2 IIIb, is mainly localized in epithelial cells, and participates in the proliferation of these cells. In contrast, a recent study has revealed that the overexpression of KGFR in salivary adenocarcinoma induces growth inhibition, cell differentiation and apoptosis. We attempted to clarify the expression and role of KGFR in normal and cancerous human gastric tissues and cancer cell lines. Reverse-transcription polymerase chain reaction and Western blot analyses showed KGFR mRNA and its protein expression in NUGC-4, KATO-III and MKN-7 gastric cancer cell lines, but not in the NS-8 cell line. Immunohistochemically, KGFR immunoreactivity was weakly detected in the luminal surface of normal gastric epithelial cells. In addition, KGFR immunoreactivity was strongly detected in the nucleus and cytoplasm of many parietal cells. In gastric cancer tissue, KGFR was expressed in the cell membrane and cytoplasm of cancer cells in 46 of 126 (36.5%) cases. KGFR expression in gastric cancer cells was significantly associated with early-type macroscopic findings, shallow invasion of the gastric wall and expansive growth type. KGFR expression tended to correlate with a good prognosis in gastric cancer. These findings indicate that KGFR expression plays important roles in the differentiation of normal gastric epithelial cells and parietal cell functions. Furthermore, a decreased expression level or the non-expression of KGFR in gastric cancer cells may be associated with the proliferation and invasion of gastric cancer cells and a poor prognosis for the patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391783

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

Review 1.  Predictive biomarkers in gastric cancer.

Authors:  C Röcken
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-19       Impact factor: 4.322

2.  Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.

Authors:  Gang Chen; Hong Qiu; Shan-Dong Ke; Shao-Ming Hu; Shi-Ying Yu; Sheng-Quan Zou
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

3.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

Review 4.  Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers.

Authors:  Kai Hung Tiong; Li Yen Mah; Chee-Onn Leong
Journal:  Apoptosis       Date:  2013-12       Impact factor: 4.677

5.  Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer.

Authors:  Masakazu Yashiro; Kenji Kuroda; Go Masuda; Tomohisa Okuno; Yuichiro Miki; Yurie Yamamoto; Tomohiro Sera; Atsushi Sugimoto; Shuhei Kushiyama; Sadaaki Nishimura; Shingo Togano; Masaichi Ohira
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort.

Authors:  Thorben Schrumpf; Hans-Michael Behrens; Jochen Haag; Sandra Krüger; Christoph Röcken
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

7.  RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer.

Authors:  Ying Kan; Xia Lu; Lijuan Feng; Xu Yang; Huan Ma; Jianhua Gong; Jigang Yang
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

8.  Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

Authors:  Sabrina Rotolo; Simona Ceccarelli; Ferdinando Romano; Luigi Frati; Cinzia Marchese; Antonio Angeloni
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

9.  In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients.

Authors:  Yasutoshi Kuboki; Christoph A Schatz; Karl Koechert; Sabine Schubert; Janine Feng; Sabine Wittemer-Rump; Karl Ziegelbauer; Thomas Krahn; Akiko Kawano Nagatsuma; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2017-08-29       Impact factor: 7.370

10.  Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer.

Authors:  Sara Pinto Teles; Patrícia Oliveira; Marta Ferreira; Joana Carvalho; Pedro Ferreira; Carla Oliveira
Journal:  Cancers (Basel)       Date:  2019-12-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.